GSK
1 year ago ⋅ English ⋅ 5 min read
Newsroom
New Shingrix data demonstrate 100% vaccine efficacy in the prevention of shingles in adults aged 50 and over in China

For media and investors only- No cases of shingles (herpes zoster) reported among the participants who received Shingrix (Recombinant Zoster Vaccine or RZV) in the randomised clinical t... Read More
GSK
1 year ago ⋅ English ⋅ 5 min read
Newsroom
New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria

For media and investors only- GSK scientists have discovered a strain of Delftia tsuruhatensis bacterium, named Tres Cantos 1 (TC1), that inhibits P. falciparum malaria parasites in mos... Read More
GSK
1 year ago ⋅ English ⋅ 6 min read
Newsroom
Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer

For media and investors only- Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy- Patients wit... Read More
GSK
1 year ago ⋅ English ⋅ 4 min read
Newsroom
Strong performance and momentum drive upgraded guidance

For media and investors onlyFull results announcement PDFDownload the Q2 2023 results announcementQ2 2023 results announcement (PDF, 1.3MB)Sales and earnings growth delivered by key gro... Read More
GSK
1 year ago ⋅ English ⋅ 6 min read
Newsroom
ViiV Healthcare’s cabotegravir for HIV prevention receives positive CHMP opinion from European Medicines Agency

For media and investors only- Cabotegravir is the first and only long-acting injectable option for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1- Positiv... Read More
GSK
1 year ago ⋅ English ⋅ 4 min read
Newsroom
New analysis shows lost ground on adult immunisation during the pandemic with 100 million doses potentially missed

For media and investors only- Despite successes in Covid-19 vaccination programmes, global uptake of some other adult vaccines fell during the same timeframe—compounding already l... Read More